Malaria

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Hydroxychloroquine sulfate

substance

Quinine sulfate

substance

Chloroquine phosphate

substance

Chloroquine hydrochloride

substance

Sulfadiazine

substance

Halofantrine hydrochloride

substance

Halofantrine

substance

Chloroquine

substance

Quinine

substance

Hydroxychloroquine

substance

Pyrimethamine

substance

Atovaquone

substance

Chlorguanide

substance

Mefloquine

substance

Mefloquine hydrochloride

substance

Lumefantrine

substance

Artemether

substance

Primaquine phosphate

substance

Primaquine

substance

Sulfadiazine sodium

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Acute kidney failure

Very frequent (80-99%)HP:0001919

Elevated C-reactive protein level

Very frequent (80-99%)HP:0011227

Headache

Very frequent (80-99%)HP:0002315

Low number of red blood cells or hemoglobin

Very frequent (80-99%)HP:0001903

Morphological abnormality of the CNS

Very frequent (80-99%)HP:0002011

Nausea and vomiting

Very frequent (80-99%)HP:0002017

Pyrexia

Very frequent (80-99%)HP:0001945

Abnormality of balance

Frequent (30-79%)HP:0002141

Cognitive deficits

Frequent (30-79%)HP:0100543

Hematological abnormality

Frequent (30-79%)HP:0001871

High blood bilirubin levels

Frequent (30-79%)HP:0002904

Laboured breathing

Frequent (30-79%)HP:0002098

Low platelet count

Frequent (30-79%)HP:0001873

Lowered consciousness

Frequent (30-79%)HP:0004372

Muscle pain

Frequent (30-79%)HP:0003326

Noninflammatory retina disease

Occasional (5-29%)HP:0000488

Overview

Treatments & Interventions

Signs & Symptoms

Related Conditions

Quick Facts